Explore
Companies
Investors
Top 50
Streams
Trending tech news
Latest investments
Latest acquisitions
Products
Automate
Trackers
Innovation Services
About Index
Index
By TNW
Log in
Register
Nektar Therapeutics
3918
Nektar Therapeutics
Technology
Biotechnology
Nektar is a clinical-stage biopharmaceutical company developing a pipeline of drug candidates designed to improve the benefits of drugs for patients.
Suggest edits
Founded
1990
Raised
$45M
Follow us
Also headquartered in San Francisco
Twitter
Uber
Instagram
Airbnb
Lyft
LinkedIn
Fitbit
Salesforce
Reddit
Twitch
Companies in the same industry
23Mofang
Lifebit
Adapsyn Bioscience
Phytonext
Novaicos
Brii Biosciences
HitGen
BioMark Health
Cullgen
ReViral Ltd
Alexa global traffic share
Twitter followers
Overview
Funding
2
Investments
1
Add info
Latest funding
$20,000,000
Post-IPO equity - 2016
$25,000,000
Venture capital - 2013
AstraZeneca
Team Size
500+
Employees
I work here
Location
San Francisco
,
United States
Headquarters
Explore San Francisco
$20,000,000
Post-IPO equity
Xconomy
Nektar Therapeutics Gets $20M in Daiichi Deal For Breast Cancer Drug
Health
The Motley Fool
Why Nektar Therapeutics Inc Is Dropping Today
The Motley Fool
Here's Why Nektar Therapeutics Inc. Rose 19% in March
The Motley Fool
Why Nektar Therapeutics Skyrocketed 30% Higher in October --
Stock markets
Health
